Personas / Equipo Humano

Guillermo Chantada

Buscador de publicaciones

Publicaciones

  • Moreno F, Sinaki B, Fandiño A, Dussel V, Orellana L and Chantada G.

    A Population-Based Study of Retinoblastoma Incidence and Survival in Argentine Children

    PEDIATRIC BLOOD & CANCER . 61(9): 1610-1615. Nº de citas: 37

    [doi:10.1002/pbc.25048]

  • Grigorovski N, Lucena E, Mattosinho C, Parareda A, Ferman S, Català-Mora J and Chantada G.

    Use of intra-arterial chemotherapy for retinoblastoma: results of a survey

    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY . 7(4): 726-730. Nº de citas: 45

    [doi:10.3980/j.issn.2222-3959.2014.04.26]

  • Chantada G, Fandiño AC, Schvartzman E, Raslawski E, Schaiquevich P and Manzitti J.

    Impact of Chemoreduction for Conservative Therapy for Retinoblastoma in Argentina

    PEDIATRIC BLOOD & CANCER . 61(5): 821-826. Nº de citas: 31

    [doi:10.1002/pbc.24857]

  • Taich P, Ceciliano A, Buitrago E, Sampor C, Fandino A, Villasante F, Lucena E, Romero L, Chantada G and Schaiquevich P.

    Clinical Pharmacokinetics of Intra-arterial Melphalan and Topotecan Combination in Patients with Retinoblastoma

    Ophthalmology . 121(4): 889-897. Nº de citas: 44

    [doi:10.1016/j.ophtha.2013.10.045]

  • Ottaviani D, Parma D, Giliberto F, Ferrer M, Fandino A, Davila MT, Chantada G and Szijan I.

    Spectrum of RB1 Mutations in Argentine Patients: 20-years Experience in the Molecular Diagnosis of Retinoblastoma

    OPHTHALMIC GENETICS . 34(4): 189-198. Nº de citas: 10

    [doi:10.3109/13816810.2012.755553]

  • Chantada G, Sampor C, Bosaleh A, Solernou V, Fandiño A and de Dávila MT.

    Comparison of staging systems for extraocular retinoblastoma: analysis of 533 patients.

    JAMA OPHTHALMOLOGY . 131(9): 1127-1134. Nº de citas: 26

    [doi:10.1001/jamaophthalmol.2013.260]

  • Laurent VE, Sampor C, Solernou V, Rossi J, Gabri M, Eandi-Eberle S, de Davila MT, Alonso DF and Chantada G.

    Detection of minimally disseminated disease in the cerebrospinal fluid of children with high-risk retinoblastoma by reverse transcriptase-polymerase chain reaction for GD2 synthase mRNA

    EUROPEAN JOURNAL OF CANCER . 49(13): 2892-2899. Nº de citas: 26

    [doi:10.1016/j.ejca.2013.04.021]

  • Chantada G, Luna-Fineman S, Sitorus RS, Kruger M, Israels T, Leal-Leal C, Bakhshi S, Qaddoumi I, Abramson DH and Doz F.

    SIOP-PODC recommendations for graduated-intensity treatment of retinoblastoma in developing countries

    PEDIATRIC BLOOD & CANCER . 60(5): 719-727. Nº de citas: 57

    [doi:10.1002/pbc.24468]

  • Schaiquevich P, Ceciliano A, Millan N, Taich P, Villasante F, Fandino AC, Dominguez J and Chantada G.

    Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma

    PEDIATRIC BLOOD & CANCER . 60(5): 766-770. Nº de citas: 43

    [doi:10.1002/pbc.24356]

  • Hesseling P, Israels T, Harif M, Chantada G and Molyneux E.

    Practical recommendations for the management of children with Endemic Burkitt Lymphoma (BL) in a resource limited setting

    PEDIATRIC BLOOD & CANCER . 60(3): 357-362. Nº de citas: 49

    [doi:10.1002/pbc.24407]